Aliberti S, Goeminne PC, O’Donnell AE, Aksamit TR, Al-Jahdali H, Barker AF, et al. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. Lancet Respir Med. 2022;10(3):298–306.
Lonni S, Chalmers JD, Goeminne PC, McDonnell MJ, Dimakou K, De Soyza A, et al. Etiology of non-cystic fbrosis bronchiectasis in adults and its correlation to disease severity. Ann Am Thorac Soc. 2015;12(12):1764–70.
Article PubMed PubMed Central Google Scholar
Martinez-García MA, Villa C, Dobarganes Y, Girón R, Maíz L, García-Clemente M, Sibila O, et al. RIBRON: The Spanish Online Bronchiectasis Registry. Characterization of the first 1912 patients. Arch Bronconeumol. 2021;57(1):28–35.
Chalmers JD, Chotirmall SH. Bronchiectasis: new therapies and new perspectives. Lancet Respir Med. 2018;6(9):715–26.
Article CAS PubMed Google Scholar
Fuschillo S, de Felice A, Balzano G. Mucosal infammation in idiopathic bronchiectasis: cellular and molecular mechanisms. Eur Respir J. 2008;31(2):396–406.
Article CAS PubMed Google Scholar
Martinez-Garcia MA, Posadas T, Sotgiu G, Blasi F, Saderi L, Aliberti S. Repeatability of circulating eosinophil measures and inhaled corticosteroids effect in bronchiectasis. A post hoc analysis of a randomized clinical trial. Arch Bronconeumol (Engl Ed). 2020;56(10):681–3.
Shoemark A, Shteinberg M, De Soyza A, Haworth C, Richardson H, Gao Y, et al. Characterisation of eosinophilic bronchiectasis: a European multicohort study. Am J Respir Crit Care Med. 2022;205(8):894–902.
Article CAS PubMed Google Scholar
Martinez-Garcia MA. Bronchiectasis and eosinophils. Arch Bronconeumol. 2021;57:671–2.
Monsó E. Look at the wood and not at the tree: the microbiome in chronic obstructive lung disease and cystic fibrosis. Arch Bronconeumol. 2020;56(1):5–6.
Cole PJ. Inflammation: a two-edged sword—the model of bronchiectasis. Eur J Respir Dis Suppl. 1986;147:6–15.
Posadas T, Oscullo G, Zaldivar E, Villa C, Dobarganes Y, Girón R, et al. C-reactive protein concentration in steady-state bronchiectasis: prognostic value of future severe exacerbations. Data from the Spanish Registry of Bronchiectasis (RIBRON). Arch Bronconeumol. 2021;57(1):21–7.
Saleh AD, Chalmers JD, De Soyza A, Fardon TC, Koustas SO, Scott J. The heterogeneity of systemic inflammation in bronchiectasis. Respir Med. 2017;127:33–9.
Chen CL, Huang Y, Yuan JJ, Li HM, Han XR, Martinez-Garcia MA, et al. The Roles of bacteria and viruses in bronchiectasis exacerbation: a prospective study. Arch Bronconeumol. 2020;56(10):621–9.
Article CAS PubMed PubMed Central Google Scholar
Martinez-Garcia MA, Miravitlles M. Bronchiectasis in COPD patients: more than a comorbidity? Int J Chron Obstruct Pulmon Dis. 2017;12:1401–11.
Article CAS PubMed PubMed Central Google Scholar
Crimi C, Ferri S, Campisi R, Crimi N. The link between asthma and bronchiectasis: state of the art. Respiration. 2020;99:463–76.
Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3):1700629.
Martínez-García MÁ, Máiz L, Olveira C, Girón RM, de la Rosa D, Blanco M, et al. Spanish guidelines on treatment of bronchiectasis in adults. Arch Bronconeumol. 2018;54(2):88–98.
Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn JS, Floto RA, et al. British Thoracic Society guideline for bronchiectasis in adults. Thorax. 2019;74(Suppl 1):1–69.
Reddel HK, Bacharier LB, Bateman ED, Brighting CE, Brusselle GG, Buhl R, et al. Global Initiative for Asthma strategy 2021. Executive summary and rationale for key changes. Arch Bronconeumol. 2022;2022(58):35–51.
Plaza V, Blanco M, García G, Korta J, Molina J, Quirce S. Highlights of the Spanish Asthma Guidelines (GEMA), version 5.0. Arch Bronconeumol. 2022;57(1):11–2.
Plaza V, Gómez-Outes A, Quirce S, Alobid I, Álvarez C, Blanco M, et al. Discrepancies between GEMA and GINA in the classification of inhaled corticosteroids. Arch Bronconeumol. 2020;56:472–3.
Pizzichini E, Pizzichini MM, Gibson P, Parameswaran K, Gleich GJ, Berman L, et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med. 1998;158(5 Pt 1):1511–7.
Article CAS PubMed Google Scholar
Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2000;356(9240):1480–5.
Article CAS PubMed Google Scholar
Brightling CE, McKenna S, Hargadon B, Birring S, Green R, Siva R, et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax. 2005;60(3):193–8.
Article CAS PubMed PubMed Central Google Scholar
Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662–71.
Bafadhel M, McCormick M, Saha S, McKenna S, Shelley M, Hargadon B, et al. Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration. 2012;83(1):36–44.
Article CAS PubMed Google Scholar
The Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2022. Available at: https://goldcopd.org/. Accessed 30 May 2022.
Miravitlles M, Calle M, Molina J, Almagro P, Tomás Gómez J, Trigueros JA, et al. Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD. Arch Bronconeumol. 2022;58(1):69–81.
Miravitlles M, Calle M, Soler-Cataluña JJ. GesEPOC 2021: One more step towards personalized treatment of COPD. Arch Bronconeumol. 2021;57(1):9–10.
Gaga M, Bentley AM, Humbert M, Barkans J, O’Brien F, Wathen CG, et al. Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax. 1998;53:685–91.
Article CAS PubMed PubMed Central Google Scholar
Angrill J, Agustí C, de Celis R, Rañó A, Gonzalez J, Solé T. Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax. 2022;57:15–9.
Guan WJ, Gao YH, Xu G, Lin ZY, Tang Y, Gu YY. Sputum matrix metalloproteinase-8 and -9 and tissue inhibitor of metalloproteinase-1 in bronchiectasis: clinical correlates and prognostic implications. Respirology. 2015;20:1073–81.
Boyton RJ, Altmann DM. Bronchiectasis: current concepts in pathogenesis, immunology, and microbiology. Annu Rev Pathol. 2016;11:523–54.
Article CAS PubMed Google Scholar
King PT. The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis. 2009;4:411–9.
Article PubMed PubMed Central Google Scholar
Tsikrika S, Dimakou K, Papaioannou AI, Hillas G, Thanos L, Kostikas K, et al. The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis. Cytokine. 2017;99:281–6.
Article CAS PubMed Google Scholar
Ravin KA, Loy M. The eosinophil in infection. Clin Rev Allerg Immunol. 2016;50:214–27.
King PT, Daviskas E. Pathogenesis and diagnosis of bronchiectasis. Breathe. 2010;6:341–51.
de la Rosa CD, López-Campos JL, Alcázar Navarrete B, Calle Rubio M, Cantón Moreno R, García-Rivero JL, et al. Consensus document on the diagnosis and treatment of chronic bronchial Infection in chronic obstructive pulmonary disease. Arch Bronconeumol. 2020;56(10):651–64.
Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet. 2018;392(10150):880–90.
Article PubMed PubMed Central Google Scholar
De la Rosa D, Martinez-Garcia MA, Barreiro E, Tabernero E, Costa R, Garcia-Clemente M, et al. Effectiveness and safety of inhaled antibiotics in patients with chronic obstructive pulmonary disease. A multicentre observational study. Arch Bronconeumol. 2022;58(1):11–21.
留言 (0)